Literature DB >> 30591510

What Causes Deep Gray Matter Atrophy in Multiple Sclerosis?

M M Schoonheim1, J J G Geurts1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30591510      PMCID: PMC7048614          DOI: 10.3174/ajnr.A5942

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  19 in total

1.  Determinants of Deep Gray Matter Atrophy in Multiple Sclerosis: A Multimodal MRI Study.

Authors:  G Pontillo; S Cocozza; R Lanzillo; C Russo; M D Stasi; C Paolella; E A Vola; C Criscuolo; P Borrelli; G Palma; E Tedeschi; V B Morra; A Elefante; A Brunetti
Journal:  AJNR Am J Neuroradiol       Date:  2018-12-20       Impact factor: 3.825

2.  Thalamus Degeneration and Inflammation in Two Distinct Multiple Sclerosis Animal Models.

Authors:  Nina Wagenknecht; Birte Becker; Miriam Scheld; Cordian Beyer; Tim Clarner; Tanja Hochstrasser; Markus Kipp
Journal:  J Mol Neurosci       Date:  2016-08-04       Impact factor: 3.444

3.  Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.

Authors:  Christina J Azevedo; Steven Y Cen; Sankalpa Khadka; Shuang Liu; John Kornak; Yonggang Shi; Ling Zheng; Stephen L Hauser; Daniel Pelletier
Journal:  Ann Neurol       Date:  2018-02-09       Impact factor: 10.422

Review 4.  Thalamus pathology in multiple sclerosis: from biology to clinical application.

Authors:  Markus Kipp; Nina Wagenknecht; Cordian Beyer; Sebastian Samer; Jens Wuerfel; Omid Nikoubashman
Journal:  Cell Mol Life Sci       Date:  2014-11-23       Impact factor: 9.261

5.  Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis.

Authors:  Laura Gaetano; Dieter A Häring; Ernst-Wilhelm Radue; Nicole Mueller-Lenke; Avinash Thakur; Davorka Tomic; Ludwig Kappos; Till Sprenger
Journal:  Neurology       Date:  2018-03-14       Impact factor: 9.910

6.  Neuroinflammatory component of gray matter pathology in multiple sclerosis.

Authors:  Elena Herranz; Costanza Giannì; Céline Louapre; Constantina A Treaba; Sindhuja T Govindarajan; Russell Ouellette; Marco L Loggia; Jacob A Sloane; Nancy Madigan; David Izquierdo-Garcia; Noreen Ward; Gabriel Mangeat; Tobias Granberg; Eric C Klawiter; Ciprian Catana; Jacob M Hooker; Norman Taylor; Carolina Ionete; Revere P Kinkel; Caterina Mainero
Journal:  Ann Neurol       Date:  2016-10-25       Impact factor: 10.422

7.  Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study.

Authors:  Anand J C Eijlers; Quinten van Geest; Iris Dekker; Martijn D Steenwijk; Kim A Meijer; Hanneke E Hulst; Frederik Barkhof; Bernard M J Uitdehaag; Menno M Schoonheim; Jeroen J G Geurts
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

8.  Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.

Authors:  Marco Vercellino; Silvia Masera; Marcella Lorenzatti; Cecilia Condello; Aristide Merola; Alessandra Mattioda; Antonella Tribolo; Elisabetta Capello; Giovanni Luigi Mancardi; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

Review 9.  Network collapse and cognitive impairment in multiple sclerosis.

Authors:  Menno M Schoonheim; Kim A Meijer; Jeroen J G Geurts
Journal:  Front Neurol       Date:  2015-04-14       Impact factor: 4.003

10.  DIR-visible grey matter lesions and atrophy in multiple sclerosis: partners in crime?

Authors:  Steven H P van de Pavert; Nils Muhlert; Varun Sethi; Claudia A M Wheeler-Kingshott; Gerard R Ridgway; Jeroen J G Geurts; Maria Ron; Tarek A Yousry; Alan J Thompson; David H Miller; Declan T Chard; Olga Ciccarelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-29       Impact factor: 10.154

View more
  1 in total

1.  Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes.

Authors:  Elisa Colato; Jonathan Stutters; Carmen Tur; Sridar Narayanan; Douglas L Arnold; Claudia A M Gandini Wheeler-Kingshott; Frederik Barkhof; Olga Ciccarelli; Declan T Chard; Arman Eshaghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-04-20       Impact factor: 10.154

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.